Article Details

German psychedelic startup Atai targets valuation of $2.3 billion in US IPO

Retrieved on: 2021-06-11 11:37:30

Tags for this article:

Click the tags to see associated articles and topics

German psychedelic startup Atai targets valuation of $2.3 billion in US IPO. View article details on hiswai:

Excerpt

(Reuters) - Atai Life Sciences B.V., backed by billionaire investor Peter Thiel, said on Friday it was looking to raise as much as $214.3 million through a ...

Article found on: www.reuters.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up